Summary: A new study suggests that daily multivitamin supplements may help slow cognitive aging and memory loss in older adults. The study found statistically significant benefits of multivitamins for memory and global cognition, indicating a potential delay in cognitive aging by about two years compared to placebo.
This research, a part of a nationwide trial, included detailed cognitive assessments in-person and through telephone and web-based methods. The findings could have significant implications for older adults looking for accessible ways to preserve brain health.
Key Facts:
Source: Mass General
By 2060, according to the Alzheimers Association, nearly one in four Americans will be in an age bracket at elevated risk of cognitive decline and Alzheimers disease unless interventions can help preserve cognitive function before deficits begin.
The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) is a large-scale, nationwide, randomized trial rigorously testing cocoa extract and multivitamin supplements directed by researchers at Mass General Brigham.
Two previously published studies of cognition in COSMOS suggested a positive effect for a daily multivitamin. COSMOS researchers now report the results of a third study of cognition in COSMOS, which focused on participants who underwent in-person assessments, together with the results of a combined analysis from the three separate studies.
The results from this latest report confirm consistent and statistically significant benefits of a daily multivitamin versus placebo for both memory and global cognition.
Results are published today inTheAmerican Journal of Clinical Nutrition.
Cognitive decline is among the top health concerns for most older adults, and a daily supplement of multivitamins has the potential as an appealing and accessible approach to slow cognitive aging, said first author Chirag Vyas, MBBS, MPH, instructor in investigation at the Department of Psychiatry at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system.
In the in-clinic study the researchers administered detailed, in-person cognitive assessments among 573 participants in the subset of COSMOS known as COSMOS-Clinic. Within COSMOS, two previous studies had tested multivitamin supplementation on cognition using telephone-based cognitive assessments (COSMOS-MIND) and online web-based cognitive assessments (COSMOS-Web).
In their prespecified analyses of data from COSMOS-Clinic, investigators observed a modest benefit for the multivitamin, compared to placebo, on global cognition over two years. There was a statistically significant benefit of multivitamin supplementation for change in episodic memory, but not in executive function/attention.
The team also conducted a meta-analysis based on the three separate studies, with non-overlapping COSMOS participants (ranging 2-3 years in treatment duration), which showed strong evidence of benefits for both global cognition and episodic memory. The authors estimate that the daily multivitamin slowed global cognitive aging by the equivalent of two years compared to placebo.
Vyas said, The meta-analysis of three separate cognition studies provides strong and consistent evidence that taking a daily multivitamin, containing more than 20 essential micronutrients, helps prevent memory loss and slow down cognitive aging.
Olivia Okereke, MD SM, senior author of the report and director of Geriatric Psychiatry at MGH, added These findings will garner attention among many older adults who are, understandably, very interested in ways to preserve brain health, as they provide evidence for the role of a daily multivitamin in supporting better cognitive aging.
The overall COSMOS trial is led by JoAnn Manson, MD, DrPH, and Howard Sesso, ScD, MPH, both of Brigham and Womens Hospital (BWH), also a founding member of Mass General Brigham. Manson, co-author of the report and Chief of the Division of Preventive Medicine at BWH, commented:
The finding that a daily multivitamin improved memory and slowed cognitive aging in three separate placebo-controlled studies in COSMOS is exciting and further supports the promise of multivitamins as a safe, accessible and affordable approach to protecting cognitive health in older adults.
The COSMOS consortium of cognitive studies represents a collaboration between MGH, BWH, Columbia University, and Wake Forest University, using both traditional and innovative approaches to assessing cognitive outcomes.
These approaches allow large numbers of participants (>5,000 in total) to be included in cognitive studies in a high-quality and cost-efficient manner. COSMOS participants are aged 60 and older and reside throughout the U.S.
Sesso, also a co-author and the associate director of the BWH Division of Preventive Medicine, added: With these three studies using different approaches for assessing cognition in COSMOS, each providing support for a daily multivitamin, it is now critical to understand the mechanisms by which a daily multivitamin may protect against memory loss and cognitive decline with a focus on nutritional status and other aging-related factors.
For example, the modifying role of baseline nutritional status on protecting against cognitive decline has been shown for the COSMOS cocoa extract intervention. A typical multivitamin such as that tested in COSMOS contains many essential vitamins and minerals that could explain its potential benefits.
COSMOS Cognition Coauthors:
Chirag M. Vyas (MGH), JoAnn E. Manson (BWH); Howard D. Sesso (BWH); Nancy R. Cook (BWH); Pamela M. Rist (BWH); Alison Weinberg (BWH); M Vinayaga Moorthy (BWH); Laura D. Baker (Wake Forest University); Mark A. Espeland (Wake Forest University); Lok-Kin Yeung (Columbia University); Adam M. Brickman (Columbia University); Olivia I. Okereke (MGH).
Disclosures:Sesso additionally reported receiving investigator-initiated grants from Pure Encapsulations and Pfizer Inc. and honoraria and/or travel for lectures from the Council for Responsible Nutrition, BASF, NIH, and the American Society of Nutrition during the conduct of the study.
Funding:COSMOS-Clinic and the cognition studies in the meta-analysis were supportedin partby investigator-initiated grants from Mars Edge, a segment of Mars Inc., and the National Institutes of Health. Multivitamin and placebo tablets and packaging were donated by Pfizer, Inc Consumer Healthcare (now Haleon).
Author: Serena Bronda Source: Mass General Contact: Serena Bronda Mass General Image: The image is credited to Neuroscience News
Original Research: The findings will appear in American Journal of Clinical Nutrition
Continue reading here:
Multivitamins May Slow Cognitive Aging - Neuroscience News
- Serotonin, GABA, and Dopamine Drive Hunger and Feeding - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- A nation exhausted: The neuroscience of why Americans are tuning out politics - The Conversation - December 23rd, 2024 [December 23rd, 2024]
- UNO Goalie and Neuroscience Grad Shines in Her Athletic and Academic Aspirations - University of Nebraska Omaha - December 23rd, 2024 [December 23rd, 2024]
- Neuroscience Major Seeks to Bridge the Generation Gap, Help Alzheimers Patients - Pomona College - December 23rd, 2024 [December 23rd, 2024]
- Spectrum 2024: Year in review - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Say what? The Transmitters top quotes of 2024 - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Targeted or Broadcast? How the Brain Processes Visual Information - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- 70 Is the New 60: Age Related Declines Slowing in Older People - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- Breathing Rhythms During Sleep Strengthen Memory Consolidation - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- How our brains think: Exploring the world of neuroscience at the Yale Peabody Museum - Connecticut Public - December 23rd, 2024 [December 23rd, 2024]
- Assembloids illuminate circuit-level changes linked to autism, neurodevelopment - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Mapping the Brain's Response to Social Rejection - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- An eye for science: Q&A with Bryan W. Jones - The Transmitter: Neuroscience News and Perspectives - December 9th, 2024 [December 9th, 2024]
- Short Sleep and High Blood Pressure Linked to Brain Aging - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Neighborhood Disadvantage Linked to Cognitive Health Risks - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Psychosis Risk Tied to Heavy Cannabis Use and Genetic Factors - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Most Teens Recover From Long Covid Within Two Years - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Opportunities and challenges of single-cell and spatially resolved genomics methods for neuroscience discovery - Nature.com - December 9th, 2024 [December 9th, 2024]
- How Evolution Shaped the Brains Understanding of Numbers - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Neuroscience Study Aboard Cunard's Queen Mary 2 Reveals Cognitive Benefits of Slow Travel at Sea - PR Newswire - November 28th, 2024 [November 28th, 2024]
- How Expectations Shape Our Gaze in a Changing World - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- To keep or not to keep: Neurophysiologys data dilemma - The Transmitter: Neuroscience News and Perspectives - November 28th, 2024 [November 28th, 2024]
- Does Alcohol Consumption Contribute to Hair Loss? - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Brains Traffic Controllers Hold Key to Learning and Memory - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead (ABBV) - Seeking Alpha - November 28th, 2024 [November 28th, 2024]
- Neuroscientists reeling from past cuts advocate for more BRAIN Initiative funding - The Transmitter: Neuroscience News and Perspectives - November 28th, 2024 [November 28th, 2024]
- Want Better Habits? Neuroscience Says This Is How to Train Your Brain - Inc. - November 28th, 2024 [November 28th, 2024]
- Dopamine and Serotonin Work in Opposition for Effective Learning - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Cunard Proves the Healing Power of Ocean Travel with Breakthrough Neuroscience Research - Travel And Tour World - November 28th, 2024 [November 28th, 2024]
- Bridging the Gap between Meditation, Neuroscience, and the Soul - openPR - November 28th, 2024 [November 28th, 2024]
- Animal Characters in Childrens Books Boost Theory of Mind - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Emotional Struggles and Tantrums in Preschoolers Linked to ADHD - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Neuroscience Says This Simple Habit Improves Cognitive Health and Makes Your Brain Act Younger - Inc. - November 20th, 2024 [November 20th, 2024]
- Premature declarations on animal consciousness hinder progress - The Transmitter: Neuroscience News and Perspectives - November 20th, 2024 [November 20th, 2024]
- Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook - Yahoo Finance - November 20th, 2024 [November 20th, 2024]
- Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development - Senior Housing News - November 20th, 2024 [November 20th, 2024]
- How to be a multidisciplinary neuroscientist - The Transmitter: Neuroscience News and Perspectives - November 20th, 2024 [November 20th, 2024]
- Neuroscience Market Expected to Reach USD 71.0 Billion by - GlobeNewswire - November 20th, 2024 [November 20th, 2024]
- Finger-Prick Test Brings Alzheimers Detection Closer to Everyone - Neuroscience News - November 20th, 2024 [November 20th, 2024]
- Dual-Gene Therapy Shows Promise for Hearing and Vision Loss - Neuroscience News - November 20th, 2024 [November 20th, 2024]
- Robots Help Unlock the Mystery of Human Sense of Self - Neuroscience News - November 20th, 2024 [November 20th, 2024]
- The neuroscience of sleep - University of South Carolina - November 20th, 2024 [November 20th, 2024]
- Stress warps fear memories in multiple ways - The Transmitter: Neuroscience News and Perspectives - November 20th, 2024 [November 20th, 2024]
- Mental Exhaustion Drives Aggressive Behavior - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- NeuroAI: A field born from the symbiosis between neuroscience, AI - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- The neuroscience of deeper learning in math - SmartBrief - November 12th, 2024 [November 12th, 2024]
- What the brain can teach artificial neural networks - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- How Anthony Zador thinks neuroscience can help improve AI - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- Discovering Cancer Therapies through Neuroscience - The New York Academy of Sciences - November 12th, 2024 [November 12th, 2024]
- Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR S&S Insider - GlobeNewswire - November 12th, 2024 [November 12th, 2024]
- Insights on Brain Aging and Lifelong Cognitive Health - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- A neuroscience PhD student at the University of Oxford has died - The Tab - November 12th, 2024 [November 12th, 2024]
- Exploring the connection between autism and sleep - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- Astrocytes star in memory storage, recall - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- Gut Bacteria Modulate Stress Responses Over Time - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- Gut Bacteria Could Hold the Key to Promoting Healthy Aging - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- Microglias pruning function called into question - The Transmitter: Neuroscience News and Perspectives - October 26th, 2024 [October 26th, 2024]
- Depression Alters Brain Circuits, Heightening Negative Perception - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- UNE Researchers Showcase Groundbreaking Work at Global Neuroscience Conference - University of New England - October 26th, 2024 [October 26th, 2024]
- Scientists discover "glue" that holds memory together in fascinating neuroscience breakthrough - PsyPost - October 26th, 2024 [October 26th, 2024]
- Systems neuroscience: combining theory and neurotechnology for a multiscale account of the brain - Nature.com - October 26th, 2024 [October 26th, 2024]
- Seaport Therapeutics adds another $225 million to coffers to embrace the golden age of neuroscience - STAT - October 26th, 2024 [October 26th, 2024]
- ANRO Investors Have Opportunity to Join Alto Neuroscience, Inc. Fraud Investigation with the Schall Law Firm - Business Wire - October 26th, 2024 [October 26th, 2024]
- Youth Face Rising Risks of Harassment and Exploitation in the Metaverse - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- Exercise During Chemotherapy Boosts Cognitive Function - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- Removing Pre-Bed Screen Time Improves Toddler Sleep - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and... - October 26th, 2024 [October 26th, 2024]
- How Visual Clutter Disrupts Information Flow in the Brain - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- Menopausal Hormone Therapys Effects on Brain Health - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- After-hours movers: McDonald's, Starbucks, Seagate, Alto Neuroscience and more - StreetInsider.com - October 26th, 2024 [October 26th, 2024]
- Alto Neuroscience Reports Topline Results from a Phase 2b Trial Evaluating ALTO-100 as a Treatment for Major Depressive Disorder - StockTitan - October 26th, 2024 [October 26th, 2024]
- Cristina Savin and Tim Vogels discuss how AI has shaped their neuroscience research - The Transmitter: Neuroscience News and Perspectives - October 13th, 2024 [October 13th, 2024]
- Should I stay (and eat) or should I go? How the brain balances hunger with competing drives - The Transmitter: Neuroscience News and Perspectives - October 13th, 2024 [October 13th, 2024]
- How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan - The Transmitter: Neuroscience News and Perspectives - October 13th, 2024 [October 13th, 2024]
- Neuroscience research sheds light on how psilocybin alters spatial awareness - PsyPost - October 13th, 2024 [October 13th, 2024]
- Newly Discovered Protein Complex Shapes Synapses and Mental Health - Neuroscience News - October 13th, 2024 [October 13th, 2024]
- The Neuroscience Behind Immersive Filmmaking - Raindance - October 13th, 2024 [October 13th, 2024]
- What are mechanisms? Unpacking the term is key to progress in neuroscience - The Transmitter: Neuroscience News and Perspectives - October 13th, 2024 [October 13th, 2024]
- Kentucky neuroscience doctor honored with national distinction - wnky.com - October 13th, 2024 [October 13th, 2024]
- Cell X Technologies and Aspen Neuroscience collaborate to address throughput and scalability in manufacturing automation to facilitate iPSC cell... - October 13th, 2024 [October 13th, 2024]